Handling unstable analytes: literature review and expert panel survey by the Japan Bioanalysis Forum Discussion Group

Author:

Niwa Makoto1ORCID,Kondo Ayaka2,Shibutani Emi3,Tsuruta Atsushi4,Shimada Eiichi5,Hirata Saaya1,Fujino Naoko6,Maruyama Shio7,Yagi Ryotaro8,Nishida Hiroshi9,Yoshimatsu Hiromichi10

Affiliation:

1. Nippon Shinyaku Co, Ltd., Nishinosho-Monguchicho 14, Kisshoin, Minami-ku, Kyoto-city, Kyoto 601-8550, Japan

2. Shionogi & Co., Ltd., Futabacho 3-1-1, Toyonaka-city, Osaka 561-0825, Japan

3. Kyorin Rimedio Co., Ltd., Office Park 11, Takaoka-city, Toyama 939-1119, Japan

4. EA Pharma Co., Ltd., Suzukicho 1-1, Kawasaki-ku, Kawasaki-city, Kanagawa 210-8681, Japan

5. Ono Pharmaceutical Co., Ltd., Sakurai 3-1-1, Shimamoto-cho, Mishima-gun, Osaka 618-8585, Japan

6. Taiho Pharmaceutical Co., Ltd., Okubo 3, Tsukuba-city, Ibaraki 300-2611, Japan

7. Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, 227-0033, Japan

8. Toray Industries, Inc., Tebiro 6-10-1, Kamakura-city, Kanagawa, 248-8555, Japan

9. GlaxoSmithKline K.K., Akasaka 1-8-1, Minato-ku, Tokyo, 107-0052, Japan

10. Kaken Pharmaceutical Co., Ltd., Gensuke 301, Fujieda-city, Shizuoka, 426-8646, Japan

Abstract

Analyzing unstable small molecule drugs and metabolites in blood continues to be challenging for bioanalysis. Although scientific countermeasures such as immediate cooling, immediate freezing, addition of enzyme inhibitors, pH adjustment, dried blood spot or derivatization have been developed, selecting the best practices has become an issue in the pharmaceutical industry as the number of drugs with such problems is increasing, even for generic drugs. In this study, we conducted a comprehensive literature review and a questionnaire survey to determine a suitable practice for evaluating instability and implementing countermeasures. Three areas of focus, matrix selection, effect of hemolysis and selection of esterase inhibitors, are discussed.

Publisher

Future Science Ltd

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

Reference79 articles.

1. Strategies in quantitative LC-MS/MS analysis of unstable small molecules in biological matrices

2. Stabilization of clinical samples collected for quantitative bioanalysis – a reflection from the European Bioanalysis Forum

3. Factors affecting the stability of drugs and drug metabolites in biological matrices

4. National Center for Biotechnology Information. National Library of Medicine, Pubmed (2021). https://pubmed.ncbi.nlm.nih.gov/

5. Clarivate Analytics, Web of Science (2021). https://clarivate.com/webofsciencegroup/solutions/web-of-science/

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3